Latest News

Mpox emergency response analysis and lessons for future equitable public health crises.

PLWHA face elevated cancer risks; screening, HPV vaccination, and coordinated care are critical.

HCV vaccine development requires addressing immune variability, access barriers, and community trust.

New MPOX clusters signal resurgence; insufficient vaccine coverage in marginalized communities.

Timeline of 2022 MPV outbreak: racial disparities in vaccination and treatment access persist.

MPV becoming endemic in MSM communities; vaccine distribution disparities impede response.

2022-2023 respiratory season tracking flu, COVID-19, and RSV with severe early indicators.

Patients face multiple monkeypox barriers: disorganized state websites, limited vaccine access, reporting gaps.

US monkeypox response: 31% of cases among Black persons, vaccine distribution equity concerns persist.

Health misinformation undermines vaccine confidence, perpetuates stigma, and drives poor policy decisions.

Flurona co-infections highlight information challenges amid pandemic fatigue and misinformation.

CDC updates STI treatment guidelines; ACIP recommends universal adult HBV vaccination and HPV catch-up.

Analysis of hepatitis B vaccine efficacy and revaccination protocols for people living with HIV.

Nobel laureate's HCV vaccine development targeting 2029 offers hope alongside access equity challenges.

COVID-19 vaccination priority for people with HIV and chronic liver disease amid immunological risks.

Assesses pandemic's ongoing impact on HIV, HCV, and SUD surveillance and care with vaccine rollout.

COVID-19 vaccine development spurs reflection on 35-year HIV vaccine search and mRNA technology advances.

Multi-state Hepatitis A and B outbreaks linked to homelessness highlight housing as public health priority.